S Weijzen,
SC Meredith,
MP Velders,
AG Elmishad,
H Schreiber,
WM Kast.
(2001)
" Pharmacokinetic differences between a T cell-tolerizing and a T cell-activating peptide.
"
J Immunol
166.
7151-7
PMID:
11390461
|
Abstract and Keywords
RW Tindle,
K Herd,
T Doan,
G Bryson,
GR Leggatt,
P Lambert,
IH Frazer,
M Street.
(2001)
" Nonspecific down-regulation of CD8+ T-cell responses in mice expressing human papillomavirus type 16 E7 oncoprotein from the keratin-14 promoter.
"
J Virol
75.
5985-97
PMID:
11390600
DOI:
10.1128/JVI.75.13.5985-5997.2001
|
Abstract and Keywords
S Szmania,
A Galloway,
M Bruorton,
P Musk,
G Aubert,
A Arthur,
H Pyle,
N Hensel,
N Ta,
L Lamb,
T Dodi,
A Madrigal,
J Barrett,
J Henslee-Downey,
F van Rhee.
(2001)
" Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes to clinical scale from a single blood draw using dendritic cells and HLA-tetramers.
"
Blood
98.
505-12
PMID:
11468143
|
Abstract and Keywords
B Gahn,
F Siller-Lopez,
AD Pirooz,
E Yvon,
S Gottschalk,
R Longnecker,
MK Brenner,
HE Heslop,
E Aguilar-Cordova,
CM Rooney.
(2001)
" Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: a potential treatment strategy for Epstein-Barr virus--positive Hodgkin's lymphoma.
"
Int J Cancer
93.
706-13
PMID:
11477583
|
Abstract and Keywords
JP McGettigan,
S Sarma,
JM Orenstein,
RJ Pomerantz,
MJ Schnell.
(2001)
" Expression and immunogenicity of human immunodeficiency virus type 1 Gag expressed by a replication-competent rhabdovirus-based vaccine vector.
"
J Virol
75.
8724-32
PMID:
11507217
|
Abstract and Keywords
XL Zhang,
S Zhao,
SH Borenstein,
Y Liu,
B Jayabalasingham,
JW Chamberlain.
(2001)
" CD8 expression up to the double-positive CD3(low/intermediate) stage of thymic differentiation is sufficient for development of peripheral functional cytotoxic T lymphocytes.
"
J Exp Med
194.
685-93
PMID:
11535636
|
Abstract and Keywords
S Fujii,
K Shimizu,
T Shimizu,
MT Lotze.
(2001)
" Interleukin-10 promotes the maintenance of antitumor CD8(+) T-cell effector function in situ.
"
Blood
98.
2143-51
PMID:
11568001
|
Abstract and Keywords
OF Bathe,
N Dalyot-Herman,
TR Malek.
(2001)
" IL-2 during in vitro priming promotes subsequent engraftment and successful adoptive tumor immunotherapy by persistent memory phenotypic CD8(+) T cells.
"
J Immunol
167.
4511-7
PMID:
11591778
|
Abstract and Keywords
CL Slingluff,
G Yamshchikov,
P Neese,
H Galavotti,
S Eastham,
VH Engelhard,
D Kittlesen,
D Deacon,
S Hibbitts,
WW Grosh,
G Petroni,
R Cohen,
C Wiernasz,
JW Patterson,
BP Conway,
WG Ross.
(2001)
" Phase I trial of a melanoma vaccine with gp100(280-288) peptide and tetanus helper peptide in adjuvant: immunologic and clinical outcomes.
"
Clin Cancer Res
7.
3012-24
PMID:
11595689
|
Abstract and Keywords
GR Gunn,
A Zubair,
C Peters,
ZK Pan,
TC Wu,
Y Paterson.
(2001)
" Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16.
"
J Immunol
167.
6471-9
PMID:
11714814
|
Abstract and Keywords